|
1
|
Dennis LK, Lynch CF and Torner JC:
Epidemiologic association between prostatitis and prostate cancer.
Urology. 60:78–83. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Roberts RO, Bergstralh EJ, Bass SE, Lieber
MM and Jacobsen SJ: Prostatitis as a risk factor for prostate
cancer. Epidemiology. 15:93–99. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Rybicki BA, Kryvenko ON, Wang Y, Jankowski
M, Trudeau S, Chitale DA, Gupta NS, Rundle A and Tang D: Racial
differences in the relationship between clinical prostatitis,
presence of inflammation in benign prostate and subsequent risk of
prostate cancer. Prostate Cancer Prostatic Dis. 19:145–150. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Boehm K, Valdivieso R, Meskawi M, Larcher
A, Schiffmann J, Sun M, Graefen M, Saad F, Parent MÉ and
Karakiewicz PI: Prostatitis, other genitourinary infections and
prostate cancer: Results from a population-based case-control
study. World J Urol. 34:425–430. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Jiang J, Li J, Yunxia Z, Zhu H, Liu J and
Pumill C: The role of prostatitis in prostate cancer:
Meta-analysis. PLoS One. 8:e851792013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Chung SD, Keller JJ and Lin HC: A
case-control study of chronic prostatitis/chronic pelvic pain
syndrome and colorectal cancer. BJU Int. 110:550–554. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Cheng I, Witte JS, Jacobsen SJ, Haque R,
Quinn VP, Quesenberry CP, Caan BJ and Van Den Eeden SK:
Prostatitis, sexually transmitted diseases, and prostate cancer:
The California Men's Health Study. PLoS One. 5:e87362010.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Krieger JN, Nyberg L Jr and Nickel JC: NIH
consensus definition and classification of prostatitis. JAMA.
282:236–237. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Perletti G, Marras E, Wagenlehner FM and
Magri V: Antimicrobial therapy for chronic bacterial prostatitis.
Cochrane Database Syst Rev. 8:CD0090712013.PubMed/NCBI
|
|
10
|
Noel GJ, Natarajan J, Chien S, Hunt TL,
Goodman DB and Abels R: Effects of three fluoroquinolones on QT
interval in healthy adults after single doses. Clin Pharmacol Ther.
73:292–303. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Arabyat RM, Raisch DW, McKoy JM and
Bennett CL: Fluoroquinolone-associated tendon-rupture: A summary of
reports in the Food and Drug Administration's adverse event
reporting system. Expert Opin Drug Saf. 14:1653–1660. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Dalhoff A: Global fluoroquinolone
resistance epidemiology and implictions for clinical use.
Interdiscip Perspect Infect Dis. 2012:9762732012.PubMed/NCBI
|
|
13
|
Sarma JB, Marshall B, Cleeve V, Tate D,
Oswald T and Woolfrey S: Effects of fluoroquinolone restriction
(from 2007 to 2012) on resistance in Enterobacteriaceae:
Interrupted time-series analysis. J Hosp Infect. 91:68–73. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Borgmann S, Jakobiak T, Gruber H, Schröder
H and Sagel U: Ciprofloxacin treatment of urinary infections
results in increased resistance of urinary E. coli to ciprofloxacin
and co-trimoxazole. Pol J Microbiol. 58:371–373. 2009.PubMed/NCBI
|
|
15
|
Brede CM and Shoskes DA: The etiology and
management of acute prostatitis. Nat Rev Urol. 8:207–212. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Etienne M, Chavanet P, Sibert L, Michel F,
Levesque H, Lorcerie B, Doucet J, Pfitzenmeyer P and Caron F: Acute
bacterial prostatitis: Heterogeneity in diagnostic criteria and
management. Retrospective multicentric analysis of 37 patients
diagnosed with acute prostatitis. BMC Infect Dis. 8:122008.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Hanus PM and Danziger LH: Treatment of
chronic bacterial prostatitis. Clin Pharm. 3:49–55. 1984.PubMed/NCBI
|
|
18
|
von Elm E, Altman DG, Egger M, Pocock SJ,
Gøtzsche PC and Vandenbroucke JP: STROBE Initiative: The
Strengthening the Reporting of Observational Studies in
Epidemiology (STROBE) statement: Guidelines for reporting
observational studies. Lancet. 370:1453–1457. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Magri V, Montanari E, Škerk V, Markotić A,
Marras E, Restelli A, Naber KG and Perletti G:
Fluoroquinolone-macrolide combination therapy for chronic bacterial
prostatitis: Retrospective analysis of pathogen eradication rates,
inflammatory findings and sexual dysfunction. Asian J Androl.
13:819–827. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Stamey TA: Prostatitis. J R Soc Med.
74:22–40. 1981.PubMed/NCBI
|
|
21
|
Magri V, Wagenlehner FM, Montanari E,
Marras E, Orlandi V, Restelli A, Torresani E, Naber KG and Perletti
G: Semen analysis in chronic bacterial prostatitis: Diagnostic and
therapeutic implications. Asian J Androl. 11:461–477. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Giubilei G, Mondaini N, Crisci A, Raugei
A, Lombardi G, Travaglini F, Del Popolo G and Bartoletti R: The
Italian version of the National Institutes of Health Chronic
Prostatitis Symptom Index. Eur Urol. 47:805–811. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Morgia G, Mucciardi G, Galì A, Madonia M,
Marchese F, Di Benedetto A, Romano G, Bonvissuto G, Castelli T,
Macchione L, et al: Treatment of chronic prostatitis/chronic pelvic
pain syndrome category IIIA with Serenoa repens plus selenium and
lycopene (Profluss) versus S. repens alone: An Italian randomized
multicenter-controlled study. Urol Int. 84:400–406. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Naber KG: European Lomefloxacin
Prostatitis Study Group: Lomefloxacin versus ciprofloxacin in the
treatment of chronic bacterial prostatitis. Int J Antimicrob
Agents. 20:18–27. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Casano RA, Bykhovskaya Y, Johnson DF,
Hamon M, Torricelli F, Bigozzi M and Fischel-Ghodsian N: Hearing
loss due to the mitochondrial A1555G mutation in Italian families.
Am J Med Genet. 79:388–391. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Scrimshaw BJ, Faed JM, Tate WP and Yun K:
Rapid identification of an A1555G mutation in human mitochondrial
DNA implicated in aminoglycoside-induced ototoxicity. J Hum Genet.
44:388–390. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Faul F, Erdfelder E, Lang AG and Buchner
A: G*Power 3: A flexible statistical power analysis program for the
social, behavioral, and biomedical sciences. Behav Res Methods.
39:175–191. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Propert KJ, McNaughton-Collins M, Leiby
BE, O'Leary MP, Kusek JW and Litwin MS: Chronic Prostatitis
Collaborative Research Network: A prospective study of symptoms and
quality of life in men with chronic prostatitis/chronic pelvic pain
syndrome: The National Institutes of Health Chronic Prostatitis
Cohort study. J Urol. 175:619–623. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wagenlehner FM, van Till JW, Magri V,
Perletti G, Houbiers JG, Weidner W and Nickel JC: National
Institutes of Health Chronic Prostatitis Symptom Index (NIH-CPSI)
symptom evaluation in multinational cohorts of patients with
chronic prostatitis/chronic pelvic pain syndrome. Eur Urol.
63:953–959. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Shang Y, Cui D and Yi S: Opening tight
junctions may be key to opening the blood-prostate barrier. Med Sci
Monit. 20:2504–2507. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Goto T, Makinose S, Ohi Y, Yamauchi D,
Kayajima T, Nagayama K and Hayami H: Diffusion of piperacillin,
cefotiam, minocycline, amikacin and ofloxacin into the prostate.
Int J Urol. 5:243–246. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Pfau A: The treatment of chronic bacterial
prostatitis. Infection. 19(Suppl 3): S160–S164. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Pfau A and Sacks T: Chronic bacterial
prostatitis: New therapeutic aspects. Br J Urol. 48:245–253. 1976.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Bundrick W, Heron SP, Ray P, Schiff WM,
Tennenberg AM, Wiesinger BA, Wright PA, Wu SC, Zadeikis N and Kahn
JB: Levofloxacin versus ciprofloxacin in the treatment of chronic
bacterial prostatitis: A randomized double-blind multicenter study.
Urology. 62:537–541. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Magri V, Trinchieri A, Pozzi G, Restelli
A, Garlaschi MC, Torresani E, Zirpoli P, Marras E and Perletti G:
Efficacy of repeated cycles of combination therapy for the
eradication of infecting organisms in chronic bacterial
prostatitis. Int J Antimicrob Agents. 29:549–556. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Fischel-Ghodsian N, Prezant TR, Chaltraw
WE, Wendt KA, Nelson RA, Arnos KS and Falk RE: Mitochondrial gene
mutation is a significant predisposing factor in aminoglycoside
ototoxicity. Am J Otolaryngol. 18:173–178. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Bitner-Glindzicz M, Pembrey M, Duncan A,
Heron J, Ring SM, Hall A and Rahman S: Prevalence of mitochondrial
1555A––>G mutation in European children. N Engl J Med.
360:640–642. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Vandebona H, Mitchell P, Manwaring N,
Griffiths K, Gopinath B, Wang JJ and Sue CM: Prevalence of
mitochondrial 1555A>G mutation in adults of European descent. N
Engl J Med. 360:642–644. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Chen G, Wang X and Fu S: Prevalence of
A1555G mitochondrial mutation in Chinese newborns and the
correlation with neonatal hearing screening. Int J Pediatr
Otorhinolaryngol. 75:532–534. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Zhao H, Li R, Wang Q, Yan Q, Deng JH, Han
D, Bai Y, Young WY and Guan MX: Maternally inherited
aminoglycoside-induced and nonsyndromic deafness is associated with
the novel C1494T mutation in the mitochondrial 12S rRNA gene in a
large Chinese family. Am J Hum Genet. 74:139–152. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Tanimoto H, Nishio H, Matsuo M and Nibu K:
A novel mitochondrial mutation, 1556C––>T, in a Japanese patient
with streptomycin-induced tinnitus. Acta Otolaryngol. 124:258–261.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Sha SH, Qiu JH and Schacht J: Aspirin to
prevent gentamicin-induced hearing loss. N Engl J Med.
354:1856–1857. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Charalabopoulos K, Karachalios G,
Baltogiannis D, Charalabopoulos A, Giannakopoulos X and Sofikitis
N: Penetration of antimicrobial agents into the prostate.
Chemotherapy. 49:269–279. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Kobayashi I, Ikawa K, Nakamura K,
Nishikawa G, Kajikawa K, Yoshizawa T, Watanabe M, Kato Y, Zennami
K, Kanao K, et al: Penetration of piperacillin-tazobactam into
human prostate tissue and dosing considerations for prostatitis
based on site-specific pharmacokinetics and pharmacodynamics. J
Infect Chemother. 21:575–580. 2015. View Article : Google Scholar : PubMed/NCBI
|
